coumarin and rosiglitazone

coumarin has been researched along with rosiglitazone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Das, N; Kumar, P; Moorthy, NS; Shrivastava, SK; Shukla, S; Srivastava, RS; Trivedi, P1
Jain, SK; Kumar, A; Parmar, VS; Prasad, AK; Raj, HG; Rastogi, RC; Sharma, SK; Singh, BK; Tyagi, R; Watterson, AC1

Other Studies

5 other study(ies) available for coumarin and rosiglitazone

ArticleYear
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Synthesis, characterization, biological evaluation and docking of coumarin coupled thiazolidinedione derivatives and its bioisosteres as PPARĪ³ agonists.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2012, Volume: 8, Issue:5

    Topics: Animals; Benzaldehydes; Computer Simulation; Coumarins; Diabetes Mellitus, Experimental; Esters; Hydantoins; Hypoglycemic Agents; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Models, Molecular; Oxazoles; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Streptozocin; Thiazolidinediones

2012
Mechanism of biochemical action of substituted 4-methylcoumarins. Part 11: Comparison of the specificities of acetoxy derivatives of 4-methylcoumarin and 4-phenylcoumarin to acetoxycoumarins: protein transacetylase.
    Bioorganic & medicinal chemistry, 2005, Jul-01, Volume: 13, Issue:13

    Topics: Acetylation; Acetyltransferases; Aflatoxin B1; Animals; Coumarins; Cytosol; DNA; Flavonoids; Glutathione Transferase; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Oxygen; Phenols; Polyphenols; Rats; Structure-Activity Relationship; Substrate Specificity

2005